
Jonathan B Ashman MD
Assistant Professor of Radiation Oncology
Join to View Full Profile
13400 E Shea BlvdScottsdale, AZ 85259
Phone+1 480-301-8000
Dr. Ashman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Jonathan B Ashman, MD, PhD is a radiation oncologist at Mayo Clinic’s Arizona campus, where he specializes in caring for patients with sarcoma, gastrointestinal malignancies, and tumors of the brain and spine. He is an Assistant Professor of Radiation Oncology at Mayo Clinic College of Medicine and Science. Treatment techniques include proton beam, intensity modulated radiotherapy, stereotactic radiosurgery, intraoperative radiotherapy, and peptide receptor radionuclide therapy. Dr. Ashman received his MD and PhD from the University of Chicago Pritzker School of Medicine. He completed his residency in radiation oncology at Memorial Sloan-Kettering Cancer Center in New York City, where he served as Chief Resident. Dr. Ashman is an associate editor for “Advances in Radiation Oncology.” U.S. News & World Report ranks Mayo Clinic Arizona as the #1 hospital in Arizona.
Education & Training
Memorial Sloan Kettering Cancer CenterResidency, Radiation Oncology, 2002 - 2006
Louis A Weiss Memorial HospitalInternship, Transitional Year, 2001 - 2002
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2001
Certifications & Licensure
CA State Medical License 2024 - 2028
AZ State Medical License 2005 - 2027
CO State Medical License 2022 - 2027
NV State Medical License 2023 - 2027
FL State Medical License 2016 - 2026
NM State Medical License 2023 - 2026
NY State Medical License 2002 - 2007
American Board of Radiology Radiation Oncology- Join now to see all
Awards, Honors, & Recognition
- CMS Meaningful Use Stage Stage 2 Certification FirstNet (Clinical), Cerner Corporation, 2013, 2015-2017
- CMS Meaningful Use Stage Stage 1 Certification FirstNet (Clinical), Cerner Corporation, 2013, 2015-2017
- CMS Meaningful Use Stage Stage 1 Certification Cerner Patient Portal and FirstNet, Cerner Corporation, 2013, 2015-2017
Clinical Trials
- Stereotactic Body Proton Radiotherapy for the Treatment of Liver Cancer Start of enrollment: 2021 Aug 24
Publications & Presentations
PubMed
- 1 citationsHypofractionated Preoperative Radiation Therapy for Extremity and Superficial Trunk Soft Tissue Sarcomas: Results of a Prospective, Phase 2 Trial.Safia K Ahmed, Meng Xu-Welliver, Madeline Dorr, Kimberly O Steinert, Matthew T Houdek
International Journal of Radiation Oncology, Biology, Physics. 2025-11-15 - Back in the RACE: (Re) Defining the Role of Radiation Therapy in Liver and Gallbladder Cancers.Aisling S Barry, Jonathan B Ashman, Krishan R Jethwa, Hyun Kim, Eric D Miller
International Journal of Radiation Oncology, Biology, Physics. 2025-09-01 - 1 citationsSimulation-free workflow for lattice radiation therapy using deep learning predicted synthetic computed tomography: A feasibility study.Libing Zhu, Nathan Y Yu, Safia K Ahmed, Jonathan B Ashman, Diego Santos Toesca
Journal of Applied Clinical Medical Physics. 2025-07-01
Press Mentions
Preoperative Hypofractionated Radiotherapy with FOLFOX for Esophageal or Gastroesophageal Junction Adenocarcinoma (PHOX)October 13th, 2023
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:










